These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 3871241
1. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ. Life Sci; 1985 Jan 21; 36(3):213-8. PubMed ID: 3871241 [Abstract] [Full Text] [Related]
2. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ. Mov Disord; 2000 May 21; 15(3):459-66. PubMed ID: 10830409 [Abstract] [Full Text] [Related]
3. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Pifl C, Schingnitz G, Hornykiewicz O. Neuroscience; 1991 May 21; 44(3):591-605. PubMed ID: 1754053 [Abstract] [Full Text] [Related]
4. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Jenner P, Marsden CD. J Neural Transm Suppl; 1986 May 21; 20():11-39. PubMed ID: 3091760 [Abstract] [Full Text] [Related]
5. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Burns RS, Markey SP, Phillips JM, Chiueh CC. Can J Neurol Sci; 1984 Feb 21; 11(1 Suppl):166-8. PubMed ID: 6608980 [Abstract] [Full Text] [Related]
6. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS. Front Biosci; 2003 Sep 01; 8():a155-66. PubMed ID: 12957824 [Abstract] [Full Text] [Related]
7. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. Proc Natl Acad Sci U S A; 1983 Jul 01; 80(14):4546-50. PubMed ID: 6192438 [Abstract] [Full Text] [Related]
8. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Pifl C, Schingnitz G, Hornykiewicz O. Neurosci Lett; 1988 Oct 05; 92(2):228-33. PubMed ID: 3263594 [Abstract] [Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? German DC, Dubach M, Askari S, Speciale SG, Bowden DM. Neuroscience; 1988 Jan 05; 24(1):161-74. PubMed ID: 3259295 [Abstract] [Full Text] [Related]
20. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Schneider JS, Yuwiler A, Markham CH. Brain Res; 1987 May 12; 411(1):144-50. PubMed ID: 2886180 [Abstract] [Full Text] [Related] Page: [Next] [New Search]